Global Clinical Packaging Organization

Small Pharma, Big Studies.

Xerimis is uniquely positioned to service the specific needs of small to mid-sized pharmaceutical companies. We know that the task of a modern day clinical packaging organization demands excellence in two key areas: an industry-leading knowledge of the landscape and its complexities along with a tireless dedication to client needs. At Xerimis, we understand the unique demands of your project, and we're here, alongside you, every step of the way.

Phase 1

Phase 1 trials are the building blocks needed for all successful drug compounds. We work with our clients to develop the most user friendly designs to help ensure that the right drug is dispensed correctly at the right time.

Xerimis plus Xerimis plus Learn More About Phase One
Packaging Consultation
On Demand Labeling
Just-in-time Shipping
Fast Turnaround

Phase 2

Phase 2 trials bring more complexity and critical packaging decisions to the clinical development team. You can rely on Xerimis to help guide you through this process.

Xerimis plus Xerimis plus Learn More About Phase Two
Blinding Services
Protocol Specific Labeling
Pooled IDP/IMP Supply Chain Management
Procurement of Ancillary Supplies

Phase 3

Phase 3 trials typically draw on a large number of global sites to fill the enrollment needs of the study. Xerimis has extensive experience with global Phase 3 trials.

Xerimis plus Xerimis plus Learn More About Phase Three
Packaging Supply Management
Translation Services
IWRS/IVRS Consultation
Supply Chain Management
Depot Management

The path through a trial is complicated.
Let us make it easy for you.

Xerimis plus Xerimis plus Get Started

Agile Ability With Global Reach.

The benefits of an international player with the agility of something much more personal

Xerimis, US (HQ)
Xerimis, UK
Xerimis, Netherlands

Real-Time Data.
From Anywhere.

We're constantly striving to provide our clients with a better, more comprehensive experience, and DashX is our latest evolution in fulfilling on that promise.

Xerimis plus Xerimis plus Register for a Free Test-Drive

Insights & News

Xerimis Partners With Area Europe on State-of-the-Art Facility in the Netherlands

We’re thrilled to be working alongside Area Europe, a UK-based construction firm specializing in workplaces, on the design and fit-out of our environmentally sustainable facility in the Netherlands. The 45,000-square-foot site marks the new location for our next global depot, enabling us to increase operations in alignment with the growing needs of our clients.

blue-plus Continue Reading

EU Clinical Trials Regulation Is Here

The EU Clinical Trials Regulation (CTR) has been in the works since 2014, but now that it’s actually here, what are the basics you need to know?

blue-plus Continue Reading

Decentralized Clinical Trials: Advancing the Trend Toward Patient-Centric Studies

Clinical trials have traditionally revolved around specific clinical sites where study participants visit and the bulk of trial activities take place. Designed to increase patient convenience and bolster the enrollment process, decentralized clinical trials (DCTs) use a virtual-first approach to bring the study to patients, wherever they are.

blue-plus Continue Reading